Video Experimental Relacionado
Updated: Feb 24, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
10.2K
Aprovechamiento de datos multifuente para resolver inconsistencias en conjuntos de datos farmacogenómicos en la
Xiaodi Li1, Trisha Das1,2, Kritib Bhattarai1,3
1Department of Artificial Intelligence and Informatics Research, Mayo Clinic, Rochester, MN, USA.
AMIA ... Annual Symposium proceedings. AMIA Symposium
|February 23, 2026
Resumen
Este estudio presenta el Aprendizaje Agregado (AL), un modelo computacional que mejora la predicción de la respuesta a los fármacos aprendiendo de las inconsistencias en múltiples conjuntos de datos farmacogenómicos. El nuevo enfoque mejora la precisión del modelo y la generalización para la identificación de biomarcadores.
Sus antecedentes:
- Los conjuntos de datos farmacogenómicos son cruciales para la identificación de biomarcadores y la predicción de la respuesta a los fármacos.
- Los modelos existentes a menudo tienen un rendimiento inferior debido a inconsistencias derivadas de la heterogeneidad intratumoral, variaciones experimentales y complejidad de subtipos celulares.
- Estas inconsistencias limitan la generalización de los modelos predictivos.
Conclusiones:
- Abordar las inconsistencias dentro y entre los conjuntos de datos farmacogenómicos es fundamental para mejorar los modelos de predicción de la respuesta a los fármacos.
- El modelo propuesto de Aprendizaje Agregado (AL) ofrece una solución prometedora para predicciones de respuesta a fármacos robustas y generalizables.
- Este enfoque tiene el potencial de avanzar en la medicina personalizada a través de una identificación de biomarcadores y una selección de tratamientos más precisas.
Videos de Conceptos Relacionados
01:29Pharmacogenomics: Identification of New Drug Targets
29
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
29
01:29Pharmacogenetics and Pharmacogenomics: Overview
51
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
51
01:27Pharmacogenetics of Drug Metabolism: Overview
32
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
32
01:12Analysis of Population Pharmacokinetic Data
843
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
843
01:27Principles of Pharmacogenetics: Types of Genetic Variants
29
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
29
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
26
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
26